SCHEMBL23761894

SCHEMBL23761894

CC/C=C\c1c(C)ccc(CC)c1C

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ TYMP P19971 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22452018 0.73 TAAR1 (0.34) —
SCHEMBL23370334 0.73 KDM4E (0.30) —
SCHEMBL8845065 0.73 CYP2A6 (0.36) TYMP
SCHEMBL23183088 0.73 CYP2A6 (0.36) TYMP
SCHEMBL8845067 0.73 CYP2A6 (0.36) TYMP
SCHEMBL19121802 0.70 TLR8 (0.33) —
SCHEMBL598503 0.69 TDP2 (0.37) —
SCHEMBL31095112 0.69 TDP2 (0.37) —
SCHEMBL28184235 0.68 GABRA1 (0.41) —
SCHEMBL28418503 0.68 KDM4E (0.44) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3464286-B1 PYRAZOLOPYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER GENENTECH INC (US) 2021-08-18 — — EP disclosed
Send feedback